Results 241 to 250 of about 260,886 (316)

Tumor immune microenvironment in non-small cell lung cancer progression. [PDF]

Front Immunol
Jiang J, Zhong M, Wang J, Zhang Z, Li W, Deng Z.   +5 more
europepmc   +1 more source

Review on enhancing clinical decision support system using machine learning

CAAI Transactions on Intelligence Technology, EarlyView.
Abstract Clinical decision‐making is a complex patient‐centred process. For an informed clinical decision, the input data is very thorough ranging from detailed family history, environmental history, social history, health‐risk assessments, and prior relevant medical cases.
Anum Masood, Usman Naseem, Junaid Rashid, Jungeun Kim, Imran Razzak   +4 more
wiley   +1 more source

BUD23 is associated with malignancy and correlates with immune infiltration in NSCLC. [PDF]

Oncol Lett
Tan Y, Ma J, Zhou J, Lu J.
europepmc   +1 more source

Viewpoint: Optimising Cancer Treatment to Reduce Its Environmental Impact

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT It is widely accepted that treatment and care for patients with cancer must and should happen, as it is what everyone would want for themselves and their loved ones. Everyone wants the best possible care, but climate change and the extreme weather that it causes are increasingly affecting everyone including patients in negative ways.
Robert Chuter, Kari Tanderup
wiley   +1 more source

Current and future immunotherapies for NSCLC. [PDF]

J Hematol Oncol
Zhou CY, Qi YF, Li HJ, Zhang C, Lin BX, Lin JT, Wu YL, Zheng MM, Zhong WZ.   +8 more
europepmc   +1 more source

Quantitative Dual‐Energy CT Perfusion Versus SPECT/CT V/Q Scintigraphy for Preoperative Lung Function Assessment: A Prospective Cohort Study

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Accurate preoperative physiological assessment is critical for high‐risk patients undergoing lung resection to predict postoperative lung function. This study compared quantitative dual‐energy CT (DECT) perfusion with SPECT/CT for lobar perfusion mapping in an at‐risk oncological cohort.
Jack Edward Liu, Kane Nicholls, Audree So, Siddharth M. Kulkarni, Anthony Tu Tran, Stephen A. Barnett, Amy Baker   +6 more
wiley   +1 more source

A Review of the Australian MRI Linac Program: From Pie in the Sky to Research Milestone

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT The Australian Magnetic Resonance Imaging (MRI) Linear Accelerator program (MRI linac) was a major research project that aimed to build and test a unique MRI linac prototype for cancer treatment. It aimed to improve radiotherapy anatomical targeting and explore physiological targeting. The purpose of this report is to summarise the development
Michael Bernard Barton, Geoffrey Paul Delaney, Peter Greer, Lois Holloway, Peter Metcalfe, Robba Rai, Trang Pham, William S. Price, David Waddington, Stuart Crozier, Paul Keall   +10 more
wiley   +1 more source

Inhibition of STAT3-mediated glycolysis by bruceine D suppresses non-small-cell lung cancer progression <i>in vitro</i> and <i>in vivo</i>. [PDF]

Cancer Biol Ther
Zhu Y, Xu X, Hong X, Zhang J, Zhou Y, Sun A, Ye Y, Xu Y, Xu H, Zhao H, Zhao C, Jin X, Yang L, Zheng J.   +13 more
europepmc   +1 more source

Factors Associated With Long‐Term Survivors With Epidermal Growth Factor Receptor Positive Non‐Small Cell Lung Cancer Treated With First or Second‐Generation Tyrosine Kinase Inhibitors: A Canadian Multi‐Center Cohort

Asia-Pacific Journal of Clinical Oncology, EarlyView.
In a multi‐center Canadian cohort of 577 patients with advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer treated with first/second‐generation TKIs, Asian ancestry and female sex predicted longer survival, while the L858R mutation predicted shorter survival.
Heather Halperin, Amanda J. W. Gibson, Ali Hussein, Mike Sung, Pascale Tomasini, Michelle Dean, Jennifer H. Law, Cheryl Ho, Vishal Navani, Natasha B. Leighl, Desiree Hao   +10 more
wiley   +1 more source

Statement of Retraction: CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway. [PDF]

Bioengineered
europepmc   +1 more source